Three Cases of Ticlopidine-induced Cholestatic Hepatitis
Journal of the Korean Neurological Association
;
: 434-436, 2002.
Article
in Korean
| WPRIM
| ID: wpr-227407
ABSTRACT
Ticlopidine hydrochloride is world-wide used antiplatelet agent that inhibit ADP pathway. Its clinical side effects are the change of the blood picture, allergic skin reaction and gastrointestinal symptoms. We report three patients with severe cholestatic hepatitis caused by ticlopidine. They developed jaundice about 20days after taking ticlopidine (500 mg/day). Infectious and immunological etiologies were excluded by serology. There was no history of alcohol or drug abuse. Their symptoms were gradually subsided for a few months after discontinuing ticlopidine.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Skin
/
Ticlopidine
/
Adenosine Diphosphate
/
Substance-Related Disorders
/
Hepatitis
/
Jaundice
Limits:
Humans
Language:
Korean
Journal:
Journal of the Korean Neurological Association
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS